Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Not yet recruiting · NCT07684274 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, plasma cell neoplasm, precancerous condition, smoldering plasma cell myeloma, vascular disorder, vascular hemostatic disease | Not yet recruiting | Not stated | 2026-07-06 | NCT07684274 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Geneseeq Technology Inc. | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 319 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||